デフォルト表紙
市場調査レポート
商品コード
1192990

患者登録ソフトウェア市場:登録タイプ別、ソフトウェアタイプ別、機能別、エンドユーザー別:世界の機会分析および産業予測、2021-2031年

Patient Registry Software Market By Registry type, By Software type, By Functionality, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: | 発行: Allied Market Research | ページ情報: 英文 339 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
患者登録ソフトウェア市場:登録タイプ別、ソフトウェアタイプ別、機能別、エンドユーザー別:世界の機会分析および産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 339 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の患者登録ソフトウェア市場は、2021年に9億9,328万米ドルで、2022年から2031年にかけてCAGR9.7%を記録し、2031年には25億827万米ドルに達すると予測されます。

患者登録は、特定の疾患、状態、または曝露によって定義される集団の特定の結果を評価するために、観察研究法を使用して均一なデータ(臨床およびその他)を収集し、所定の科学、臨床、または政策の目的を果たす組織的システムであると定義されています。患者登録は、ある状態や経験を共有する患者集団に関する標準化された情報を、1つまたは複数の目的のために収集することです。研究機関、学術的な臨床機関、または個々の研究チームは、特定の研究課題に使用できる観察データ収集の目的で登録システムを確立しています。

患者登録ソフトウェア市場の成長は、電子医療記録(EHR)の使用量の増加、慢性疾患の蔓延、医療に対する政府支援の増加、老年人口の急増、病院や研究機関における患者登録の潜在的メリットの増加によって促進されると考えられます。さらに、保存されたデータの市販後調査への利用の増加や、患者登録の構築に対する政府の取り組みの急増も、市場の成長を後押ししています。しかし、データのセキュリティとプライバシーに関する懸念や、熟練した人材の不足が市場成長の妨げとなっています。逆に、技術に関する意識の高まりは、同市場に有利な機会を生み出すと予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 患者登録ソフトウェア市場:登録タイプ別

  • 概要
    • 市場規模・予測
  • 疾患別登録
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析: 国別
    • 疾患登録・患者登録ソフトウェア市場:タイプ別
      • 心血管登録の市場規模及び予測:地域別
      • 糖尿病登録の市場規模・予測:地域別
      • がん登録の市場規模・予測:地域別
      • レアディーズ登録の市場規模・予測:地域別
      • その他の市場規模・予測:地域別
  • 医療サービス登録
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 製品登録
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
    • 製品登録・患者登録ソフトウェア市場:タイプ別
      • 医療機器登録の市場規模及び予測:地域別
      • 薬物登録市場規模推移・予測: 地域別

第5章 患者登録ソフトウェア市場:ソフトウェアタイプ別

  • 概要
    • 市場規模・予測
  • スタンドアロン型
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別分析
  • 統合型
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第6章 患者登録ソフトウェア市場:機能別

  • 概要
    • 市場規模・予測
  • ポピュレーションヘルスマネジメント
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 健康情報交換
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 患者ケアマネジメント
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 医療研究・臨床試験
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • その他
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第7章 患者登録ソフトウェア市場:エンドユーザー別

  • 概要
    • 市場規模・予測
  • 病院
    • 主な市場動向、成長要因と機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 政府機関、第三者機関
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 製薬会社、バイオテクノロジー会社、医療機器会社
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • その他
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第8章 患者登録ソフトウェア市場:地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米の市場規模・予測:登録タイプ別
      • 北米の疾患登録・患者登録ソフトウェア市場:タイプ別
      • 北米の製品登録・患者登録ソフトウェア市場:タイプ別
    • 北米市場規模・予測:ソフトウェアタイプ別
    • 北米市場の規模・予測:機能別
    • 北米市場の規模・予測:エンドユーザー別
    • 北米市場の規模・予測:国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州の市場規模・予測:登録タイプ別
      • 欧州の疾患登録・患者登録ソフトウェア市場:タイプ別
      • 欧州の製品登録・患者登録ソフトウェア市場:タイプ別
    • 欧州市場規模・予測:ソフトウェアタイプ別
    • 欧州市場規模・予測:機能別
    • 欧州市場規模・予測:エンドユーザー別
    • 欧州市場規模・予測:国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他の欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測:登録タイプ別
      • アジア太平洋地域の疾患登録・患者登録ソフトウェア市場:タイプ別
      • アジア太平洋地域の製品登録・患者登録ソフトウェア市場:タイプ別
    • アジア太平洋地域の市場規模・予測:ソフトウェアタイプ別
    • アジア太平洋地域の市場規模・予測:機能別
    • アジア太平洋地域の市場規模・予測:エンドユーザー別
    • アジア太平洋地域の市場規模・予測:国別
      • 日本
      • 中国
      • オーストラリア
      • インド
      • 韓国
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測:登録タイプ別
      • LAMEA疾病登録・患者登録ソフトウェア市場:タイプ別
      • LAMEAの製品登録・患者登録ソフトウェア市場:タイプ別
    • LAMEAの市場規模・予測:ソフトウェアタイプ別
    • LAMEAの市場規模・予測:機能別
    • LAMEAの市場規模・予測:エンドユーザー別
    • LAMEA市場の規模・予測:国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ
      • LAMEAのその他の地域

第9章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第10章 企業プロファイル

  • Conduent, Inc.
  • Dacima Software Inc.
  • Elekta AB(pub)
  • FIGmd, Inc.
  • IBM Corp
  • ImageTrend, Inc.
  • IQVIA Holdings
  • McKesson Corporation
  • OpenText Corporation
  • Optum, Inc.
  • Ordinal Data, Inc.
  • Premier, Inc.
図表

LIST OF TABLES

  • TABLE 1. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. PATIENT REGISTRY SOFTWARE MARKET, FOR DISEASE REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 5. PATIENT REGISTRY SOFTWARE MARKET, FOR CARDIOVASCULAR REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. PATIENT REGISTRY SOFTWARE MARKET, FOR DIABETES REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. PATIENT REGISTRY SOFTWARE MARKET, FOR CANCER REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. PATIENT REGISTRY SOFTWARE MARKET, FOR RARE DISEASE REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. PATIENT REGISTRY SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. PATIENT REGISTRY SOFTWARE MARKET, FOR HEALTH SERVICE REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH SERVICE REGISTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. GLOBAL PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 15. PATIENT REGISTRY SOFTWARE MARKET, FOR MEDICAL DEVICE REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. PATIENT REGISTRY SOFTWARE MARKET, FOR DRUG REGISTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 18. PATIENT REGISTRY SOFTWARE MARKET, FOR STANDALONE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. PATIENT REGISTRY SOFTWARE MARKET FOR STANDALONE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. PATIENT REGISTRY SOFTWARE MARKET, FOR INTEGRATED, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. PATIENT REGISTRY SOFTWARE MARKET FOR INTEGRATED, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 23. PATIENT REGISTRY SOFTWARE MARKET, FOR POPULATION HEALTH MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. PATIENT REGISTRY SOFTWARE MARKET, FOR HEALTH INFORMATION EXCHANGE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. PATIENT REGISTRY SOFTWARE MARKET, FOR PATIENT CARE MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 28. PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 29. PATIENT REGISTRY SOFTWARE MARKET, FOR MEDICAL RESEARCH AND CLINICAL STUDIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 30. PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH AND CLINICAL STUDIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 31. PATIENT REGISTRY SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 32. PATIENT REGISTRY SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 33. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 34. PATIENT REGISTRY SOFTWARE MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 35. PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 36. PATIENT REGISTRY SOFTWARE MARKET, FOR GOVERNMENT AND THIRD PARTY ORGANIZATIONS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 37. PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT AND THIRD PARTY ORGANIZATIONS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 38. PATIENT REGISTRY SOFTWARE MARKET, FOR PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 39. PATIENT REGISTRY SOFTWARE MARKET FOR PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 40. PATIENT REGISTRY SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 41. PATIENT REGISTRY SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 42. PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 43. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 44. NORTH AMERICA DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 45. NORTH AMERICA PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 47. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 48. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 50. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 51. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 52. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 53. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 54. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 55. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 56. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 57. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 59. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 60. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 61. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 62. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 63. EUROPE DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 64. EUROPE PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 66. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 67. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 69. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 70. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 71. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 72. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 73. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 74. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 75. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 76. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. UK PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. UK PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 79. UK PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 80. UK PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 82. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 83. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 84. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 85. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 86. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 87. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 88. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 90. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 91. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 92. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 94. ASIA-PACIFIC DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 95. ASIA-PACIFIC PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 96. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 97. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 98. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 99. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 100. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 101. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 102. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 103. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 104. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 105. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 106. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 107. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 108. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 109. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 110. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 111. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 112. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 113. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 114. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 115. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 116. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 117. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 118. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 119. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 120. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 121. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 122. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 123. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 124. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 125. LAMEA DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 126. LAMEA PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 127. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 128. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 129. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 130. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 131. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 132. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 133. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 134. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 135. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 136. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 137. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 138. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 139. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 140. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 141. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 142. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 143. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
  • TABLE 144. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
  • TABLE 145. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
  • TABLE 146. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 147.CONDUENT, INC.: COMPANY SNAPSHOT
  • TABLE 148.CONDUENT, INC.: OPERATING SEGMENTS
  • TABLE 149.CONDUENT, INC.: PRODUCT PORTFOLIO
  • TABLE 150.CONDUENT, INC.: NET SALES,
  • TABLE 151.CONDUENT, INC.: KEY STRATERGIES
  • TABLE 152.DACIMA SOFTWARE INC.: COMPANY SNAPSHOT
  • TABLE 153.DACIMA SOFTWARE INC.: OPERATING SEGMENTS
  • TABLE 154.DACIMA SOFTWARE INC.: PRODUCT PORTFOLIO
  • TABLE 155.DACIMA SOFTWARE INC.: NET SALES,
  • TABLE 156.DACIMA SOFTWARE INC.: KEY STRATERGIES
  • TABLE 157.ELEKTA AB (PUB): COMPANY SNAPSHOT
  • TABLE 158.ELEKTA AB (PUB): OPERATING SEGMENTS
  • TABLE 159.ELEKTA AB (PUB): PRODUCT PORTFOLIO
  • TABLE 160.ELEKTA AB (PUB): NET SALES,
  • TABLE 161.ELEKTA AB (PUB): KEY STRATERGIES
  • TABLE 162.FIGMD, INC.: COMPANY SNAPSHOT
  • TABLE 163.FIGMD, INC.: OPERATING SEGMENTS
  • TABLE 164.FIGMD, INC.: PRODUCT PORTFOLIO
  • TABLE 165.FIGMD, INC.: NET SALES,
  • TABLE 166.FIGMD, INC.: KEY STRATERGIES
  • TABLE 167.IBM CORP: COMPANY SNAPSHOT
  • TABLE 168.IBM CORP: OPERATING SEGMENTS
  • TABLE 169.IBM CORP: PRODUCT PORTFOLIO
  • TABLE 170.IBM CORP: NET SALES,
  • TABLE 171.IBM CORP: KEY STRATERGIES
  • TABLE 172.IMAGETREND, INC.: COMPANY SNAPSHOT
  • TABLE 173.IMAGETREND, INC.: OPERATING SEGMENTS
  • TABLE 174.IMAGETREND, INC.: PRODUCT PORTFOLIO
  • TABLE 175.IMAGETREND, INC.: NET SALES,
  • TABLE 176.IMAGETREND, INC.: KEY STRATERGIES
  • TABLE 177.IQVIA HOLDINGS: COMPANY SNAPSHOT
  • TABLE 178.IQVIA HOLDINGS: OPERATING SEGMENTS
  • TABLE 179.IQVIA HOLDINGS: PRODUCT PORTFOLIO
  • TABLE 180.IQVIA HOLDINGS: NET SALES,
  • TABLE 181.IQVIA HOLDINGS: KEY STRATERGIES
  • TABLE 182.MCKESSON CORPORATION: COMPANY SNAPSHOT
  • TABLE 183.MCKESSON CORPORATION: OPERATING SEGMENTS
  • TABLE 184.MCKESSON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 185.MCKESSON CORPORATION: NET SALES,
  • TABLE 186.MCKESSON CORPORATION: KEY STRATERGIES
  • TABLE 187.OPENTEXT CORPORATION: COMPANY SNAPSHOT
  • TABLE 188.OPENTEXT CORPORATION: OPERATING SEGMENTS
  • TABLE 189.OPENTEXT CORPORATION: PRODUCT PORTFOLIO
  • TABLE 190.OPENTEXT CORPORATION: NET SALES,
  • TABLE 191.OPENTEXT CORPORATION: KEY STRATERGIES
  • TABLE 192.OPTUM, INC.: COMPANY SNAPSHOT
  • TABLE 193.OPTUM, INC.: OPERATING SEGMENTS
  • TABLE 194.OPTUM, INC.: PRODUCT PORTFOLIO
  • TABLE 195.OPTUM, INC.: NET SALES,
  • TABLE 196.OPTUM, INC.: KEY STRATERGIES
  • TABLE 197.ORDINAL DATA, INC.: COMPANY SNAPSHOT
  • TABLE 198.ORDINAL DATA, INC.: OPERATING SEGMENTS
  • TABLE 199.ORDINAL DATA, INC.: PRODUCT PORTFOLIO
  • TABLE 200.ORDINAL DATA, INC.: NET SALES,
  • TABLE 201.ORDINAL DATA, INC.: KEY STRATERGIES
  • TABLE 202.PREMIER, INC.: COMPANY SNAPSHOT
  • TABLE 203.PREMIER, INC.: OPERATING SEGMENTS
  • TABLE 204.PREMIER, INC.: PRODUCT PORTFOLIO
  • TABLE 205.PREMIER, INC.: NET SALES,
  • TABLE 206.PREMIER, INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.PATIENT REGISTRY SOFTWARE MARKET SEGMENTATION
  • FIGURE 2.PATIENT REGISTRY SOFTWARE MARKET,2021-2031
  • FIGURE 3.PATIENT REGISTRY SOFTWARE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.PATIENT REGISTRY SOFTWARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PATIENT REGISTRY SOFTWARE MARKET,BY REGISTRY TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF HEALTH SERVICE REGISTRY PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 16.PATIENT REGISTRY SOFTWARE MARKET,BY SOFTWARE TYPE,2021(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF STANDALONE PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF INTEGRATED PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 19.PATIENT REGISTRY SOFTWARE MARKET,BY FUNCTIONALITY,2021(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF POPULATION HEALTH MANAGEMENT PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HEALTH INFORMATION EXCHANGE PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PATIENT CARE MANAGEMENT PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF MEDICAL RESEARCH AND CLINICAL STUDIES PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 25.PATIENT REGISTRY SOFTWARE MARKET,BY END USER,2021(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOSPITALS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF GOVERNMENT AND THIRD PARTY ORGANIZATIONS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF OTHERS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
  • FIGURE 30.PATIENT REGISTRY SOFTWARE MARKET BY REGION,2021
  • FIGURE 31.U.S. PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 32.CANADA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 33.MEXICO PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 34.GERMANY PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 35.FRANCE PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 36.UK PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 37.ITALY PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 38.SPAIN PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 39.REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 40.JAPAN PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 41.CHINA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 42.AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 43.INDIA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 44.SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 45.REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 46.BRAZIL PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 47.SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 48.SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 49.REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54.COMPETITIVE DASHBOARD
  • FIGURE 55.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 56.CONDUENT, INC..: NET SALES ,($MILLION)
  • FIGURE 57.DACIMA SOFTWARE INC..: NET SALES ,($MILLION)
  • FIGURE 58.ELEKTA AB (PUB).: NET SALES ,($MILLION)
  • FIGURE 59.FIGMD, INC..: NET SALES ,($MILLION)
  • FIGURE 60.IBM CORP.: NET SALES ,($MILLION)
  • FIGURE 61.IMAGETREND, INC..: NET SALES ,($MILLION)
  • FIGURE 62.IQVIA HOLDINGS.: NET SALES ,($MILLION)
  • FIGURE 63.MCKESSON CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 64.OPENTEXT CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 65.OPTUM, INC..: NET SALES ,($MILLION)
  • FIGURE 66.ORDINAL DATA, INC..: NET SALES ,($MILLION)
  • FIGURE 67.PREMIER, INC..: NET SALES ,($MILLION)
目次
Product Code: A02490

The global patient registry software market was valued at $993.28 million in 2021, and is projected to reach $2,508.27 million by 2031, registering a CAGR of 9.7% from 2022 to 2031.

Patient registries have been defined as an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves a predetermined scientific, clinical, or policy purpose. A patient registry is a collection for one or more purposes of standardized information about a group of patients who share a condition or experience. Research institutions, academic clinical institutions, or individual research teams establish a registry system for the purpose of observational data collection that can be used for a specific research agenda.

Growth of the patient registry software market is driven by increase in the usage of electronic health records (EHRs), increase in prevalence of chronic diseases, rise in government support for healthcare, surge in geriatric population and increase in potential benefits of patient registry in  hospitals and research organizations. Furthermore, the increase in usage of the stored data for post-marketing surveillance and surge in government initiatives to build patient registries help increase the growth of the market. However, concerns related to the security and privacy of the data and dearth of skilled resources hinder the market growth. Conversely, increase in awareness regarding technologies is expected to create lucrative opportunities for the market.

The patient registry software market is segmented on the basis of registry type, software type, functionality, end user and region. On the basis of registry type, the market is divided into disease registry, health service registry and product registry. The disease registry segment is further segmented by type into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. On the basis of software type, the market is classified into standalone and integrated. On the basis of functionality, the market is classified into population health management, health information exchange, patient care management, medical research and clinical studies and others. On the basis of end user, the market is classified into hospitals, government and third party organizations, pharma, biotech and medical device companies and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The key market players operating in this market include Allscripts healthcare solutions, Inc., Conduent Inc., Dacima Software Inc., Elekta Solutions AB, ImageTrend, Inc., IQVIA Holdings Inc., McKesson Corporation, MRO Corp. (FIGmd, Inc.), Open Text Corporation, Ordinal data, Inc., Premier, Inc, UnitedHealth Group Inc. (Optum Inc.).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient registry software market analysis from 2021 to 2031 to identify the prevailing patient registry software market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the patient registry software market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global patient registry software market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Registry type

  • Disease Registry
    • Type
    • Cardiovascular Registry
    • Diabetes Registry
    • Cancer Registry
    • Rare Disease Registry
    • Others
  • Health Service Registry
  • Product Registry
    • Type
    • Medical device Registry
    • Drug Registry

By Software type

  • Standalone
  • Integrated

By Functionality

  • Population Health Management
  • Health Information Exchange
  • Patient Care Management
  • Medical Research and Clinical Studies
  • Others

By End User

  • Hospitals
  • Government and third party organizations
  • Pharma, Biotech and Medical Device Companies
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Conduent, Inc.
    • Dacima Software Inc.
    • Elekta AB (pub)
    • FIGmd, Inc.
    • IBM Corp
    • ImageTrend, Inc.
    • IQVIA Holdings
    • McKesson Corporation
    • OpenText Corporation
    • Optum, Inc.
    • Ordinal Data, Inc.
    • Premier, Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Disease Registry
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Disease Registry Patient Registry Software Market by Type
      • 4.2.4.1 Cardiovascular Registry Market size and forecast, by region
      • 4.2.4.2 Diabetes Registry Market size and forecast, by region
      • 4.2.4.3 Cancer Registry Market size and forecast, by region
      • 4.2.4.4 Rare Disease Registry Market size and forecast, by region
      • 4.2.4.5 Others Market size and forecast, by region
  • 4.3 Health Service Registry
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Product Registry
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
    • 4.4.4 Product Registry Patient Registry Software Market by Type
      • 4.4.4.1 Medical device Registry Market size and forecast, by region
      • 4.4.4.2 Drug Registry Market size and forecast, by region

CHAPTER 5: PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Standalone
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Integrated
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country

CHAPTER 6: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Population Health Management
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Health Information Exchange
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Patient Care Management
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country
  • 6.5 Medical Research and Clinical Studies
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market analysis by country
  • 6.6 Others
    • 6.6.1 Key market trends, growth factors and opportunities
    • 6.6.2 Market size and forecast, by region
    • 6.6.3 Market analysis by country

CHAPTER 7: PATIENT REGISTRY SOFTWARE MARKET, BY END USER

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 Hospitals
    • 7.2.1 Key market trends, growth factors and opportunities
    • 7.2.2 Market size and forecast, by region
    • 7.2.3 Market analysis by country
  • 7.3 Government and third party organizations
    • 7.3.1 Key market trends, growth factors and opportunities
    • 7.3.2 Market size and forecast, by region
    • 7.3.3 Market analysis by country
  • 7.4 Pharma, Biotech and Medical Device Companies
    • 7.4.1 Key market trends, growth factors and opportunities
    • 7.4.2 Market size and forecast, by region
    • 7.4.3 Market analysis by country
  • 7.5 Others
    • 7.5.1 Key market trends, growth factors and opportunities
    • 7.5.2 Market size and forecast, by region
    • 7.5.3 Market analysis by country

CHAPTER 8: PATIENT REGISTRY SOFTWARE MARKET, BY REGION

  • 8.1 Overview
    • 8.1.1 Market size and forecast
  • 8.2 North America
    • 8.2.1 Key trends and opportunities
    • 8.2.2 North America Market size and forecast, by Registry type
      • 8.2.2.1 North America Disease Registry Patient Registry Software Market by Type
      • 8.2.2.2 North America Product Registry Patient Registry Software Market by Type
    • 8.2.3 North America Market size and forecast, by Software type
    • 8.2.4 North America Market size and forecast, by Functionality
    • 8.2.5 North America Market size and forecast, by End User
    • 8.2.6 North America Market size and forecast, by country
      • 8.2.6.1 U.S.
      • 8.2.6.1.1 Market size and forecast, by Registry type
      • 8.2.6.1.2 Market size and forecast, by Software type
      • 8.2.6.1.3 Market size and forecast, by Functionality
      • 8.2.6.1.4 Market size and forecast, by End User
      • 8.2.6.2 Canada
      • 8.2.6.2.1 Market size and forecast, by Registry type
      • 8.2.6.2.2 Market size and forecast, by Software type
      • 8.2.6.2.3 Market size and forecast, by Functionality
      • 8.2.6.2.4 Market size and forecast, by End User
      • 8.2.6.3 Mexico
      • 8.2.6.3.1 Market size and forecast, by Registry type
      • 8.2.6.3.2 Market size and forecast, by Software type
      • 8.2.6.3.3 Market size and forecast, by Functionality
      • 8.2.6.3.4 Market size and forecast, by End User
  • 8.3 Europe
    • 8.3.1 Key trends and opportunities
    • 8.3.2 Europe Market size and forecast, by Registry type
      • 8.3.2.1 Europe Disease Registry Patient Registry Software Market by Type
      • 8.3.2.2 Europe Product Registry Patient Registry Software Market by Type
    • 8.3.3 Europe Market size and forecast, by Software type
    • 8.3.4 Europe Market size and forecast, by Functionality
    • 8.3.5 Europe Market size and forecast, by End User
    • 8.3.6 Europe Market size and forecast, by country
      • 8.3.6.1 Germany
      • 8.3.6.1.1 Market size and forecast, by Registry type
      • 8.3.6.1.2 Market size and forecast, by Software type
      • 8.3.6.1.3 Market size and forecast, by Functionality
      • 8.3.6.1.4 Market size and forecast, by End User
      • 8.3.6.2 France
      • 8.3.6.2.1 Market size and forecast, by Registry type
      • 8.3.6.2.2 Market size and forecast, by Software type
      • 8.3.6.2.3 Market size and forecast, by Functionality
      • 8.3.6.2.4 Market size and forecast, by End User
      • 8.3.6.3 UK
      • 8.3.6.3.1 Market size and forecast, by Registry type
      • 8.3.6.3.2 Market size and forecast, by Software type
      • 8.3.6.3.3 Market size and forecast, by Functionality
      • 8.3.6.3.4 Market size and forecast, by End User
      • 8.3.6.4 Italy
      • 8.3.6.4.1 Market size and forecast, by Registry type
      • 8.3.6.4.2 Market size and forecast, by Software type
      • 8.3.6.4.3 Market size and forecast, by Functionality
      • 8.3.6.4.4 Market size and forecast, by End User
      • 8.3.6.5 Spain
      • 8.3.6.5.1 Market size and forecast, by Registry type
      • 8.3.6.5.2 Market size and forecast, by Software type
      • 8.3.6.5.3 Market size and forecast, by Functionality
      • 8.3.6.5.4 Market size and forecast, by End User
      • 8.3.6.6 Rest of Europe
      • 8.3.6.6.1 Market size and forecast, by Registry type
      • 8.3.6.6.2 Market size and forecast, by Software type
      • 8.3.6.6.3 Market size and forecast, by Functionality
      • 8.3.6.6.4 Market size and forecast, by End User
  • 8.4 Asia-Pacific
    • 8.4.1 Key trends and opportunities
    • 8.4.2 Asia-Pacific Market size and forecast, by Registry type
      • 8.4.2.1 Asia-Pacific Disease Registry Patient Registry Software Market by Type
      • 8.4.2.2 Asia-Pacific Product Registry Patient Registry Software Market by Type
    • 8.4.3 Asia-Pacific Market size and forecast, by Software type
    • 8.4.4 Asia-Pacific Market size and forecast, by Functionality
    • 8.4.5 Asia-Pacific Market size and forecast, by End User
    • 8.4.6 Asia-Pacific Market size and forecast, by country
      • 8.4.6.1 Japan
      • 8.4.6.1.1 Market size and forecast, by Registry type
      • 8.4.6.1.2 Market size and forecast, by Software type
      • 8.4.6.1.3 Market size and forecast, by Functionality
      • 8.4.6.1.4 Market size and forecast, by End User
      • 8.4.6.2 China
      • 8.4.6.2.1 Market size and forecast, by Registry type
      • 8.4.6.2.2 Market size and forecast, by Software type
      • 8.4.6.2.3 Market size and forecast, by Functionality
      • 8.4.6.2.4 Market size and forecast, by End User
      • 8.4.6.3 Australia
      • 8.4.6.3.1 Market size and forecast, by Registry type
      • 8.4.6.3.2 Market size and forecast, by Software type
      • 8.4.6.3.3 Market size and forecast, by Functionality
      • 8.4.6.3.4 Market size and forecast, by End User
      • 8.4.6.4 India
      • 8.4.6.4.1 Market size and forecast, by Registry type
      • 8.4.6.4.2 Market size and forecast, by Software type
      • 8.4.6.4.3 Market size and forecast, by Functionality
      • 8.4.6.4.4 Market size and forecast, by End User
      • 8.4.6.5 South Korea
      • 8.4.6.5.1 Market size and forecast, by Registry type
      • 8.4.6.5.2 Market size and forecast, by Software type
      • 8.4.6.5.3 Market size and forecast, by Functionality
      • 8.4.6.5.4 Market size and forecast, by End User
      • 8.4.6.6 Rest of Asia-Pacific
      • 8.4.6.6.1 Market size and forecast, by Registry type
      • 8.4.6.6.2 Market size and forecast, by Software type
      • 8.4.6.6.3 Market size and forecast, by Functionality
      • 8.4.6.6.4 Market size and forecast, by End User
  • 8.5 LAMEA
    • 8.5.1 Key trends and opportunities
    • 8.5.2 LAMEA Market size and forecast, by Registry type
      • 8.5.2.1 LAMEA Disease Registry Patient Registry Software Market by Type
      • 8.5.2.2 LAMEA Product Registry Patient Registry Software Market by Type
    • 8.5.3 LAMEA Market size and forecast, by Software type
    • 8.5.4 LAMEA Market size and forecast, by Functionality
    • 8.5.5 LAMEA Market size and forecast, by End User
    • 8.5.6 LAMEA Market size and forecast, by country
      • 8.5.6.1 Brazil
      • 8.5.6.1.1 Market size and forecast, by Registry type
      • 8.5.6.1.2 Market size and forecast, by Software type
      • 8.5.6.1.3 Market size and forecast, by Functionality
      • 8.5.6.1.4 Market size and forecast, by End User
      • 8.5.6.2 Saudi Arabia
      • 8.5.6.2.1 Market size and forecast, by Registry type
      • 8.5.6.2.2 Market size and forecast, by Software type
      • 8.5.6.2.3 Market size and forecast, by Functionality
      • 8.5.6.2.4 Market size and forecast, by End User
      • 8.5.6.3 South Africa
      • 8.5.6.3.1 Market size and forecast, by Registry type
      • 8.5.6.3.2 Market size and forecast, by Software type
      • 8.5.6.3.3 Market size and forecast, by Functionality
      • 8.5.6.3.4 Market size and forecast, by End User
      • 8.5.6.4 Rest of LAMEA
      • 8.5.6.4.1 Market size and forecast, by Registry type
      • 8.5.6.4.2 Market size and forecast, by Software type
      • 8.5.6.4.3 Market size and forecast, by Functionality
      • 8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Key developments

CHAPTER 10: COMPANY PROFILES

  • 10.1 Conduent, Inc.
    • 10.1.1 Company overview
    • 10.1.2 Company snapshot
    • 10.1.3 Operating business segments
    • 10.1.4 Product portfolio
    • 10.1.5 Business performance
    • 10.1.6 Key strategic moves and developments
  • 10.2 Dacima Software Inc.
    • 10.2.1 Company overview
    • 10.2.2 Company snapshot
    • 10.2.3 Operating business segments
    • 10.2.4 Product portfolio
    • 10.2.5 Business performance
    • 10.2.6 Key strategic moves and developments
  • 10.3 Elekta AB (pub)
    • 10.3.1 Company overview
    • 10.3.2 Company snapshot
    • 10.3.3 Operating business segments
    • 10.3.4 Product portfolio
    • 10.3.5 Business performance
    • 10.3.6 Key strategic moves and developments
  • 10.4 FIGmd, Inc.
    • 10.4.1 Company overview
    • 10.4.2 Company snapshot
    • 10.4.3 Operating business segments
    • 10.4.4 Product portfolio
    • 10.4.5 Business performance
    • 10.4.6 Key strategic moves and developments
  • 10.5 IBM Corp
    • 10.5.1 Company overview
    • 10.5.2 Company snapshot
    • 10.5.3 Operating business segments
    • 10.5.4 Product portfolio
    • 10.5.5 Business performance
    • 10.5.6 Key strategic moves and developments
  • 10.6 ImageTrend, Inc.
    • 10.6.1 Company overview
    • 10.6.2 Company snapshot
    • 10.6.3 Operating business segments
    • 10.6.4 Product portfolio
    • 10.6.5 Business performance
    • 10.6.6 Key strategic moves and developments
  • 10.7 IQVIA Holdings
    • 10.7.1 Company overview
    • 10.7.2 Company snapshot
    • 10.7.3 Operating business segments
    • 10.7.4 Product portfolio
    • 10.7.5 Business performance
    • 10.7.6 Key strategic moves and developments
  • 10.8 McKesson Corporation
    • 10.8.1 Company overview
    • 10.8.2 Company snapshot
    • 10.8.3 Operating business segments
    • 10.8.4 Product portfolio
    • 10.8.5 Business performance
    • 10.8.6 Key strategic moves and developments
  • 10.9 OpenText Corporation
    • 10.9.1 Company overview
    • 10.9.2 Company snapshot
    • 10.9.3 Operating business segments
    • 10.9.4 Product portfolio
    • 10.9.5 Business performance
    • 10.9.6 Key strategic moves and developments
  • 10.10 Optum, Inc.
    • 10.10.1 Company overview
    • 10.10.2 Company snapshot
    • 10.10.3 Operating business segments
    • 10.10.4 Product portfolio
    • 10.10.5 Business performance
    • 10.10.6 Key strategic moves and developments
  • 10.11 Ordinal Data, Inc.
    • 10.11.1 Company overview
    • 10.11.2 Company snapshot
    • 10.11.3 Operating business segments
    • 10.11.4 Product portfolio
    • 10.11.5 Business performance
    • 10.11.6 Key strategic moves and developments
  • 10.12 Premier, Inc.
    • 10.12.1 Company overview
    • 10.12.2 Company snapshot
    • 10.12.3 Operating business segments
    • 10.12.4 Product portfolio
    • 10.12.5 Business performance
    • 10.12.6 Key strategic moves and developments